NK cell-mediated lysis of autologous human oligodendrocytes

Journal of Neuroimmunology

Volumn 116, Issue 1, 2001, Pages 107-115

  Morse, Rachel H A ^a   Séguin, Rosanne ^a   McCrea, Ellie L ^a   Antel, Jack P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cytotoxicity; Human; Multiple sclerosis; Natural killer cells; Oligodendrocyte

Indexed keywords

ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 2;

ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL POPULATION; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; FETUS; HUMAN; HUMAN CELL; MICROGLIA; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY;

ANTIGENS, CD3; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; MONOCYTES; OLIGODENDROGLIA; RECOMBINANT PROTEINS;

EID: 0035341490     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00289-2     Document Type: Article

References (58)

1. Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression
2. Neuronal progenitors-learning from the hippocampus
3. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity
4. Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity
5. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis
6. Effect of endogenous cortisol levels on natural killer activity in healthy humans
7. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis
8. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
9. Target cell expression of MHC antigens is not (always) a turn-off signal to natural killer cells
10. Production of hematopoietic colony-stimulating factors by human natural killer cells
11. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent-mediated injury
12. + T cells in a transfer model of colitis
13. Cytokine-induced cytotoxic function expressed by lymphocytes of the innate immune system: Distinguishing characteristics of NK and LAK based on functional and molecular markers
14. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon
15. Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients
16. Cortisol at physiological concentrations and prostaglandin E2 are additive inhibitors of human natural killer cell activity
17. Immunohistochemical studies of adult human glial cells
18. Human fetal thymus and bone marrow contain target cells for natural killer cells
19. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain
20. MHC class I restricted lysis of human oligodendrocytes by myelin basic peptide-specific CD8 T lymphocytes
21. Immune regulation: A critical link between NK cells and CTLs
22. Turning on natural killer cells
23. Natural killer cells: Definition of a cell type rather than a function
24. Multiple sclerosis: Oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules
25. Perforin, fas ligand, and tumour necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells
26. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity
27. Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cell from normal donors
28. Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements
29. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
30. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106
31. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis
32. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis
33. Human NK cells: Origin, clonality, specificity and receptors
34. Evaluation of cell-mediated cytotoxicity assay utilizing 125-iododeoxyuridine-labeled tissue-culture target cells
35. Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system
36. + T cell-mediated apoptosis of activated astrocytes in Theiler's virus-induced demyelination
37. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
38. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
39. Serum/CSF levels of IL-2. IL-2R1, TNF-alpha, and IL-1-beta in multiple sclerosis (MS): Expected lack of clinical utility
40. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: Expected lack of clinical utility
41. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: A key role in brain inflammation?
42. Absence of natural killer (NK) cell activity against oligodendrocytes in multiple sclerosis
43. Lymophokine-activated killer (LAK) and adherent LAK (A-LAK) activity in multiple sclerosis
44. Tumorigenicity of adenovirus transformed cells: Region E1A of adenovirus 12 confers resistance to natural killer cells
45. p46, A novel natural killer cell-specific surface molecule that mediates cell activation
46. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density against autologous, allogeneic or xenogeneic target cells
47. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: Implications for autoimmunity
48. Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions
49. Biology of natural killer cells
50. Effect of cortisol and ACTH on corticosteroid-suppressed peripheral blood natural killer cells from healthy volunteers and patients with Crohn's disease
51. Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: A benign cell population with potent cytotoxic activity
52. + myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule
53. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis
54. + cytotoxic T-lymphocyte clones isolated from multiple sclerosis patients
55. Targeting of human dendritic cells by autologous NK cells
56. Culture of glial cells from human brain biopsies
57. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells
58. Glucocorticoid regulation of natural cytotoxicity: Effects of cortisol on the phenotype and function of a cloned human natural killer cell line